FDA Approves Reintroduced Cortrophin Gel for MS Exacerbations

FDA Approves Reintroduced Cortrophin Gel for MS Exacerbations

310945

FDA Approves Reintroduced Cortrophin Gel for MS Exacerbations

The injectable ACTH gel medication Cortrophin Gel (repository corticotropin injection), first introduced in the U.S. in the 1950s, will now be relaunched as a treatment for acute flare-ups in multiple sclerosis (MS) and other autoimmune conditions, following its approval by the U.S. Food and Drug Administration (FDA). In addition to MS, the FDA has now approved Cortrophin Gel for indications that include acute exacerbations from rheumatoid arthritis, and excess protein in the urine due to…

You must be logged in to read/download the full post.